Document


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 _______________________________________________________________________ 

FORM 10-Q
(Mark One)
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 30, 2017
or
¨
TRANSITION REPORT PURSUANT OF SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission File Number: 001-33268
centralgardenlogo.jpg
Delaware
 
68-0275553
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
1340 Treat Blvd., Suite 600, Walnut Creek, California 94597
(Address of principal executive offices)
(925) 948-4000
(Registrant’s telephone number, including area code)
_________ ______________________________________________________________ 

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    ý  Yes    ¨  No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    ý  Yes    ¨  No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
ý
  
Accelerated filer
 
¨
 
 
 
 
Non-accelerated filer
 
¨ (Do not check if a smaller reporting company)
  
Smaller reporting company
 
¨
 
 
 
 
Emerging growth company
 
¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ¨  Yes    ý  No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
 
 
Common Stock Outstanding as of February 1, 2018
12,160,023

 
 
Class A Common Stock Outstanding as of February 1, 2018
38,070,180

 
 
Class B Stock Outstanding as of February 1, 2018
1,652,262

 
 

Table of Contents

 
PART I. FINANCIAL INFORMATION
 
 
 
 
Item 1.
 
 
 
 
 
 
Item 2.
Item 3.
Item 4.
 
PART II. OTHER INFORMATION
 
 
 
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This Form 10-Q includes “forward-looking statements.” Forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events, future revenues or performance, capital expenditures, plans or intentions relating to acquisitions, our competitive strengths and weaknesses, our business strategy and the trends we anticipate in the industries in which we operate and other information that is not historical information. When used in this Form 10-Q, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements, including, without limitation, our future earnings expectations, are based upon our current expectations and various assumptions. Our expectations, beliefs and projections are expressed in good faith, and we believe there is a reasonable basis for them, but we cannot assure you that our expectations, beliefs and projections will be realized.
There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in this Form 10-Q. Important factors that could cause our actual results to differ materially from the forward-looking statements we make in this Form 10-Q are set forth in the Form 10-K for the fiscal year ended September 30, 2017, including the factors described in the section entitled “Item 1A – Risk Factors.” If any of these risks or uncertainties materializes, or if any of our underlying assumptions are incorrect, our actual results may differ significantly from the results that we express in, or imply by, any of our forward-looking statements. We do not undertake any obligation to revise these forward-looking statements to reflect future events or circumstances, except as required by law. Presently known risk factors include, but are not limited to, the following factors:
 
•
seasonality and fluctuations in our operating results and cash flow;
•fluctuations in market prices for seeds and grains and other raw materials;
•our inability to pass through cost increases in a timely manner;
•
our dependence upon key executives;

2
Table of Contents

•
risks associated with new product introductions, including the risk that our new products will not produce sufficient sales to recoup our investment;
•
fluctuations in energy prices, fuel and related petrochemical costs;
•declines in consumer spending during economic downturns;
•inflation, deflation and other adverse macro-economic conditions;
•supply shortages in pet birds, small animals and fish;
•adverse weather conditions;
•risks associated with our acquisition strategy;
•access to and cost of additional capital;
•dependence on a small number of customers for a significant portion of our business;
•consolidation trends in the retail industry;
•competition in our industries;
•potential goodwill or intangible asset impairment;
•continuing implementation of an enterprise resource planning information technology system;
•our inability to protect our trademarks and other proprietary rights;
•potential environmental liabilities;
•risk associated with international sourcing;
•litigation and product liability claims;
•regulatory issues;
•the impact of product recalls;
•potential costs and risks associated with actual or potential cyber attacks;
•the impact of the U.S. Tax Cuts and Jobs Act;
•the voting power associated with our Class B stock; and
•potential dilution from issuance of authorized shares.


3
Table of Contents

PART I. FINANCIAL INFORMATION
 
Item 1.
Financial Statements

CENTRAL GARDEN & PET COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
(Unaudited)
 
 
December 30,
2017
 
December 24,
2016
 
September 30,
2017
ASSETS
 
 
 
 
 
Current assets:
 
 
 
 
 
Cash and cash equivalents
$
283,466

 
$
6,581

 
$
32,397

Restricted cash
12,419

 
10,981

 
12,645

Accounts receivable (less allowance for doubtful accounts of $20,481, $22,157 and $21,436)
235,075

 
192,224

 
237,868

Inventories
440,421

 
430,171

 
382,101

Prepaid expenses and other
22,519

 
22,399

 
18,045

Total current assets
993,900

 
662,356

 
683,056

Land, buildings, improvements and equipment—net
179,230

 
169,836

 
180,913

Goodwill
256,275

 
230,385

 
256,275

Other intangible assets—net
113,726

 
92,851

 
116,067

Other assets
74,221

 
61,326

 
70,595

Total
$
1,617,352

 
$
1,216,754

 
$
1,306,906

LIABILITIES AND EQUITY
 
 
 
 
 
Current liabilities:
 
 
 
 
 
Accounts payable
$
124,583

 
$
135,237

 
$
103,283

Accrued expenses
100,004

 
94,494

 
116,549

Current portion of long-term debt
372

 
397

 
375

Total current liabilities
224,959

 
230,128

 
220,207

Long-term debt
690,964

 
395,011

 
395,278

Deferred taxes and other long-term obligations
39,478

 
31,659

 
54,279

Equity:
 
 
 
 
 
Common stock, 12,160,023, 11,998,472, and 12,160,023 shares outstanding at December 30, 2017, December 24, 2016 and September 30, 2017
122

 
120

 
122

Class A common stock, $0.01 par value: 38,029,367, 37,558,042 and 38,019,736 shares outstanding at December 30, 2017, December 24, 2016 and September 30, 2017
380

 
375

 
380

Class B stock, $0.01 par value: 1,652,262 shares outstanding
16

 
16

 
16

Additional paid-in capital
396,702

 
392,402

 
396,790

Accumulated earnings
265,576

 
168,138

 
239,329

Accumulated other comprehensive loss
(907
)
 
(1,802
)
 
(951
)
Total Central Garden & Pet Company shareholders’ equity
661,889

 
559,249

 
635,686

Noncontrolling interest
62

 
707

 
1,456

Total equity
661,951

 
559,956

 
637,142

Total
$
1,617,352

 
$
1,216,754

 
$
1,306,906

See notes to condensed consolidated financial statements.

4
Table of Contents

CENTRAL GARDEN & PET COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(Unaudited)
 
 
Three Months Ended
 
December 30,
2017
 
December 24,
2016
Net sales
$
442,011

 
$
419,498

Cost of goods sold and occupancy
310,174

 
298,820

Gross profit
131,837

 
120,678

Selling, general and administrative expenses
109,316

 
100,740

Operating income
22,521

 
19,938

Interest expense
(7,405
)
 
(6,873
)
Interest income
187

 
38

Other expense
(3,089
)
 
(967
)
Income before income taxes and noncontrolling interest
12,214

 
12,136

Income tax (benefit) expense
(14,236
)
 
4,347

Income including noncontrolling interest
26,450

 
7,789

Net income attributable to noncontrolling interest
203

 
152

Net income attributable to Central Garden & Pet Company
$
26,247

 
$
7,637

Net income per share attributable to Central Garden & Pet Company:
 
 
 
Basic
$
0.52

 
$
0.15

Diluted
$
0.50

 
$
0.15

Weighted average shares used in the computation of net income per share:
 
 
 
Basic
50,730

 
49,665

Diluted
52,695

 
51,810

See notes to condensed consolidated financial statements.


5


CENTRAL GARDEN & PET COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)
(Unaudited)
 
 
Three Months Ended
 
December 30,
2017
 
December 24,
2016
Income including noncontrolling interest
$
26,450

 
$
7,789

Other comprehensive income (loss):
 
 
 
Foreign currency translation
44

 
(508
)
Total comprehensive income
26,494

 
7,281

Comprehensive income attributable to noncontrolling interest
203

 
152

Comprehensive income attributable to Central Garden & Pet Company
$
26,291

 
$
7,129

See notes to condensed consolidated financial statements.


6
Table of Contents

CENTRAL GARDEN & PET COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
 
 
Three Months Ended
 
December 30,
2017
 
December 24,
2016
Cash flows from operating activities:
 
 
 
Net income
$
26,450

 
$
7,789

Adjustments to reconcile net income to net cash used by operating activities:
 
 
 
Depreciation and amortization
11,163

 
10,009

Amortization of deferred financing costs
377

 
341

Stock-based compensation
2,680

 
2,687

Excess tax benefits from stock-based awards
—

 
(4,356
)
Deferred income taxes
(15,765
)
 
3,527

Gain on sale of property and equipment
(18
)
 
(95
)
Gain on sale of facility
—

 
(2,050
)
Other
820

 
798

Change in assets and liabilities (excluding businesses acquired):
 
 
 
Accounts receivable
2,822

 
11,590

Inventories
(58,252
)
 
(67,678
)
Prepaid expenses and other assets
(2,252
)
 
(1,238
)
Accounts payable
23,059

 
31,863

Accrued expenses
(16,546
)
 
(6,420
)
Other long-term obligations
1,249

 
(80
)
Net cash used by operating activities
(24,213
)
 
(13,313
)
Cash flows from investing activities:
 
 
 
Additions to property and equipment
(8,186
)
 
(12,968
)
Payments to acquire companies, net of cash acquired
—

 
(60,042
)
Proceeds from the sale of business, facility and other assets
—

 
7,960

Change in restricted cash
226

 
(71
)
Investments
(6,555
)
 
(2,000
)
Other investing activities
(1,200
)
 
(265
)
Net cash used in investing activities
(15,715
)
 
(67,386
)
Cash flows from financing activities:
 
 
 
Repayments of long-term debt
(7
)
 
(74
)
Proceeds from issuance of long-term debt
300,000

 
—

Borrowings under revolving line of credit
23,000

 
1,000

Repayments under revolving line of credit
(23,000
)
 
(1,000
)
Repurchase of common stock, including shares surrendered for tax withholding
(2,768
)
 
(7,913
)
Payment of contingent consideration liability
(93
)
 
(860
)
Distribution to noncontrolling interest
(1,597
)
 
(1,018
)
Payment of financing costs
(4,558
)
 
—

Excess tax benefits from stock-based awards
—

 
4,356

Net cash provided (used) by financing activities
290,977

 
(5,509
)
Effect of exchange rate changes on cash and cash equivalents
20

 
(193
)
Net increase (decrease) in cash and cash equivalents
251,069

 
(86,401
)
Cash and equivalents at beginning of period
32,397

 
92,982

Cash and equivalents at end of period
$
283,466

 
$
6,581

Supplemental information:
 
 
 
Cash paid for interest
$
12,757

 
$
13,034

See notes to condensed consolidated financial statements.

7


CENTRAL GARDEN & PET COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Three Months Ended December 30, 2017
(Unaudited)
1.
Basis of Presentation
The condensed consolidated balance sheets of Central Garden & Pet Company and subsidiaries (the “Company” or “Central”) as of December 30, 2017 and December 24, 2016, the condensed consolidated statements of operations, the condensed consolidated statements of cash flows and the condensed consolidated statements of comprehensive income for the three months ended December 30, 2017 and December 24, 2016, have been prepared by the Company, without audit. In the opinion of management, the interim financial statements include all normal recurring adjustments necessary for a fair statement of the results for the interim periods presented.
For the Company’s foreign business in the UK, the local currency is the functional currency. Assets and liabilities are translated using the exchange rate in effect at the balance sheet date. Income and expenses are translated at the average exchange rate for the period. Deferred taxes are not provided on translation gains and losses because the Company expects earnings of its foreign subsidiary to be permanently reinvested. Transaction gains and losses are included in results of operations. See Note 8, Supplemental Equity Information, for further detail.
Due to the seasonal nature of the Company’s garden business, the results of operations for the three months ended December 30, 2017 are not indicative of the operating results that may be expected for the entire fiscal year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies and financial notes thereto, included in the Company’s 2017 Annual Report on Form 10-K, which has previously been filed with the Securities and Exchange Commission. The September 30, 2017 balance sheet presented herein was derived from the audited financial statements.
Noncontrolling Interest
Noncontrolling interest in the Company’s condensed consolidated financial statements represents the 20% interest not owned by Central in a consolidated subsidiary. Since the Company controls this subsidiary, its financial statements are consolidated with those of the Company, and the noncontrolling owner’s 20% share of the subsidiary’s net assets and results of operations is deducted and reported as noncontrolling interest on the consolidated balance sheets and as net income (loss) attributable to noncontrolling interest in the consolidated statements of operations. See Note 8, Supplemental Equity Information, for additional information.
Restricted Cash
Restricted cash includes cash and highly liquid instruments that are used as collateral for stand-alone letter of credit agreements related to normal business transactions. These agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder, which will affect the amount of cash the Company has available for other uses. The amount of cash collateral in these segregated accounts was approximately $12.4 million, $11.0 million and $12.6 million as of December 30, 2017, December 24, 2016 and September 30, 2017, respectively, and is reflected in Restricted cash on the condensed consolidated balance sheets.
Recent Accounting Pronouncements and U.S. Tax Reform
Accounting Pronouncements Recently Adopted
Stock Based Compensation

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, Stock Compensation, which is intended to simplify several aspects of the accounting for share-based payment award transactions. ASU 2016-09 (i) requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled, (ii) requires classification of excess tax benefits as an operating activity in the statement of cash flows rather than a financing activity, (iii) eliminates the requirement to defer recognition of an excess tax benefit until the benefit is realized through a reduction to taxes payable, (iv) modifies statutory withholding tax requirements and (v) provides for a policy election to account for forfeitures as they occur. The Company adopted ASU 2016-09 on October 1, 2017. As a result of the adoption of ASU 2016-09, the Company now records excess tax benefits currently in its provision for income taxes. Upon adoption, the Company determined it had no previously unrecognized excess tax benefits. Additionally, the Company elected to account for forfeitures as they occur using a modified retrospective transition method, which requires the Company to record a cumulative-effect adjustment to accumulated earnings, and the Company determined that the cumulative impact was immaterial. The Company presents its excess tax benefits as a component of operating cash flows rather than financing cash flows on a prospective basis.

8
Table of Contents

Inventory Measurement
In July 2015, the FASB issued ASU 2015-11 (ASU 2015-11), Simplifying the Measurement of Inventory. Under ASU 2015-11, inventory will be measured at the “lower of cost and net realizable value” and options that currently exist for “market value” will be eliminated. The standard defines net realizable value as the “estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” No other changes were made to the current guidance on inventory measurement. The Company adopted ASU 2015-11 on October 1, 2017. The adoption of ASU 2015-11 did not have a material impact on the Company's consolidated financial statements.
Accounting Standards Not Yet Adopted
Revenue Recognition
In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (ASU 2014-09), Revenue from Contracts with Customers. This update was issued as Accounting Standards Codification Topic 606. The core principle of this amendment is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. On July 9, 2015, the FASB deferred the effective date of ASU 2014-09 for one year. ASU 2014-09 is now effective for the Company in the first quarter of its fiscal year ending September 28, 2019.

Early adoption is permitted. The guidance permits two implementation approaches, one requiring retrospective application of the new standard with restatement of prior years and one requiring prospective application of the new standard with disclosure of results under old standards. The Company is still in the early stages of assessing the adoption method and analyzing the impact of the adoption of this update on its consolidated financial statements. As part of its assessment work to-date, the Company has formed an implementation work team and conducted training sessions on the new ASU’s revenue recognition model and begun the process of scoping of revenue streams under the new ASU. Additionally, the Company is also analyzing the impact of the new standard on its current accounting policies and internal controls. Upon completion of these and other assessments, the Company will evaluate the impact of adopting the new standard on its consolidated financial statements.
Leases
In February 2016, the FASB issued ASU 2016-02 (ASU 2016-02), Leases (Topic 842). ASU 2016-02 requires companies to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. ASU 2016-02 is effective for the Company in its first quarter of fiscal 2020 on a modified retrospective basis and earlier adoption is permitted. The Company is currently evaluating the impact of its pending adoption of ASU 2016-02 on its consolidated financial statements, and it currently expects that most of its operating lease commitments will be subject to the new standard and the Company will record material operating lease liabilities and right-of-use assets upon the adoption of ASU 2016-02.
Statement of Cash Flows
In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15) . The ASU provides additional clarification guidance on the classification of certain cash receipts and payments in the statement of cash flows. The new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2017 with early adoption permitted. The Company is currently evaluating the impact the adoption of ASU 2016-15 will have on its consolidated financial statements.
In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force) (ASU 2016-18). This ASU clarifies the presentation of restricted cash on the statement of cash flows. Amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning and ending cash balances on the statement of cash flows. ASU 2016-18 is effective for fiscal years, and interim periods within those fiscal years beginning after December 15, 2017, or the Company's first quarter of fiscal 2019, with early adoption permitted. The Company held restricted cash balances of $12.4 million, $11.0 million and $12.6 million as of December 30, 2017, December 24, 2016 and September 30, 2017, respectively. The Company does not anticipate the adoption of ASU 2016-18 will have a material impact on its consolidated financial statements and related disclosures.
Business Combinations

In January 2017, the FASB issued ASU No. 2017-01, Clarifying the Definition of a Business (ASU 2017-01), which requires an evaluation of whether substantially all of the fair value of assets acquired is concentrated in a single identifiable asset or a group of similar

9
Table of Contents

identifiable assets. If so, the transaction does not qualify as a business. The guidance also requires an acquired business to include at least one substantive process and narrows the definition of outputs. The Company is required to apply this guidance to annual periods beginning after December 15, 2017, including interim periods within those periods, or the Company's first quarter of fiscal 2019. The adoption of this ASC may have an impact on accounting for any future acquisitions the Company may have.

    Goodwill

In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other: Simplifying the Test for Goodwill Impairment. The new guidance simplifies the subsequent measurement of goodwill by removing the second step of the two-step impairment test. The amendment requires an entity to perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The new guidance is effective for annual periods or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019, or the Company's first quarter of fiscal 2021. The amendment should be applied on a prospective basis. Based on the Company's most recent annual goodwill impairment test performed as of June 25, 2017, there were no reporting units for which the carrying amount of the reporting unit exceeded its fair value; therefore, this ASU would not currently have an impact on the Company's consolidated financial statements and related disclosures. However, if upon adoption the carrying amount of a reporting unit exceeds its fair value, the Company would be impacted by the amount of impairment recognized.

Income Taxes

On December 22, 2017, the U.S. Tax Cuts and Jobs Act (the “Tax Reform Act”) was signed into law by the U.S. government. The Tax Reform Act significantly revised the U.S. corporate income tax code by, among other things, lowering the U.S. federal corporate tax rate from 35% to 21% effective January 1, 2018. U.S. GAAP requires that the impact of tax legislation be recognized in the period in which the law was enacted.
The Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 (“SAB 118”) on December 22, 2017.  This guidance allows registrants a “measurement period,” not to exceed one year from the date of enactment, to complete their accounting for the tax effects of the Act.  SAB 118 further directs that during the measurement period, registrants who are able to make reasonable estimates of the tax effects of the Act should include those amounts in their financial statements as “provisional” amounts.  Registrants should reflect adjustments over subsequent periods as they are able to refine their estimates and complete their accounting for the tax effects of the Act.  We have made reasonable estimates and recorded provisional amounts within the meaning of SAB 118.  Any adjustments recorded to the provisional amounts through the first quarter of fiscal 2019 will be included as an adjustment to tax expense. The provisional amounts incorporate assumptions made based upon the Company’s current interpretation of the Tax Reform Act and may change as the Company receives additional clarification and implementation guidance.

As a result of the Tax Reform Act, the Company recorded a provisional tax benefit of $16.3 million due to the remeasurement of its deferred tax assets and liabilities in the three months ended December 30, 2017. This tax benefit represents provisional amounts and the Company’s current best estimates.


2.
Fair Value Measurements
ASC 820 establishes a single authoritative definition of fair value, a framework for measuring fair value and expands disclosure of fair value measurements. ASC 820 requires financial assets and liabilities to be categorized based on the inputs used to calculate their fair values as follows:
Level 1 - Quoted prices in active markets for identical assets or liabilities.
Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
Level 3 - Unobservable inputs for the asset or liability, which reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).
The Company’s financial instruments include cash and equivalents, short term investments consisting of bank certificates of deposit, accounts receivable and payable, derivative instruments, short-term borrowings, and accrued liabilities. The carrying amount of these instruments approximates fair value because of their short-term nature.

10


Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of December 30, 2017 (in thousands): 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Liabilities:
 
 
 
 
 
 
 
 
Liability for contingent consideration (a)
 
$
—

 
$
—

 
$
9,058

 
$
9,058

Total liabilities
 
$
—

 
$
—

 
$
9,058

 
$
9,058

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of December 24, 2016 (in thousands): 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Liabilities:
 
 
 
 
 
 
 
 
Liability for contingent consideration (a)
 
$
—

 
$
—

 
$
4,253

 
$
4,253

Total liabilities
 
$
—

 
$
—

 
$
4,253

 
$
4,253

The following table presents our financial assets and liabilities at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of September 30, 2017: 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Liabilities:
 
 
 
 
 
 
 
 
Liability for contingent consideration (a)
 
$
—

 
$
—

 
$
9,343

 
$
9,343

Total liabilities
 
$
—

 
$
—

 
$
9,343

 
$
9,343

 
(a)
The liability for contingent consideration relates to an earn-out for B2E, acquired in December 2012, future performance-based contingent payments for Hydro-Organics Wholesale, Inc., acquired in October 2015, and future performance-based contingent payment for Segrest, Inc., acquired in October 2016. The fair value of the estimated contingent consideration arrangement is determined based on the Company’s evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity. This is presented as part of long-term liabilities in the Company's consolidated balance sheets.
The following table provides a summary of the changes in fair value of the Company's Level 3 financial instruments for the periods ended December 30, 2017 and December 24, 2016 (in thousands):
 
Amount
Balance September 30, 2017
$
9,343

Estimated contingent performance-based consideration established at the time of acquisition
—

Changes in the fair value of contingent performance-based payments established at the time of acquisition
(192
)
Performance-based payments
(93
)
Balance December 30, 2017
$
9,058

 
 
 
Amount
Balance September 24, 2016
$
5,113

Estimated contingent performance-based consideration established at the time of acquisition
(860
)
Changes in the fair value of contingent performance-based payments established at the time of acquisition
—

Balance December 24, 2016
$
4,253

Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis
The Company measures certain non-financial assets and liabilities, including long-lived assets, goodwill and intangible assets, at fair value on a non-recurring basis. Fair value measurements of non-financial assets and non-financial liabilities are used primarily in the impairment analyses of long-lived assets, goodwill and other intangible assets. During the three-month periods ended December 30, 2017 and December 24, 2016, the Company was not required to measure any significant non-financial assets and liabilities at fair value.

11


Fair Value of Other Financial Instruments
In December 2017, the Company issued $300 million aggregate principal amount of 5.125% senior notes due February 2028 (the "2028 Notes"). The estimated fair value of the Company's 2028 Notes as of December 30, 2017 was $300.8 million compared to a carrying value of $295.5 million.
In November 2015, the Company issued $400 million aggregate principal amount of 6.125% senior notes due November 2023 (the “2023 Notes”). The estimated fair value of the Company’s 2023 Notes as of December 30, 2017, December 24, 2016 and September 24, 2016 was $424.2 million, $421.4 million and $427.9 million, respectively, compared to a carrying value of $395.4 million, $394.6 million and $395.2 million, respectively.

3.
Acquisitions
K&H Manufacturing
On April 28, 2017, the Company purchased K&H Manufacturing, a producer of premium pet supplies and the largest marketer of heated pet products in the country, for a purchase price of approximately $48.0 million. The purchase price exceeded the estimated fair value of the net tangible assets acquired by approximately $41.8 million, which is included in other assets in the Company’s condensed consolidated balance sheet as of December 30, 2017. The Company has not yet finalized the allocation of the purchase price to the fair value of the intangible assets acquired. K&H sells branded pet products under the K&H and K&H Pet brands. The acquisition is expected to complement the Company's existing dog and cat business.


4.
Inventories, net
Inventories, net of allowance for obsolescence, consist of the following (in thousands):
 
 
 
December 30, 2017
 
December 24, 2016
 
September 30, 2017
Raw materials
 
$
120,710

 
$
125,324

 
$
116,591

Work in progress
 
13,778

 
21,024

 
16,394

Finished goods
 
291,812

 
273,730

 
241,420

Supplies
 
14,121

 
10,093

 
7,696

Total inventories, net
 
$
440,421

 
$
430,171

 
$
382,101

 
5.
Goodwill
The Company tests goodwill for impairment annually (as of the first day of the fourth fiscal quarter), or whenever events occur or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount, by first assessing qualitative factors to determine whether it is more likely than not the fair value of the reporting unit is less than its carrying amount. If it is determined that it is more likely than not the fair value of the reporting unit is greater than its carrying amount, it is unnecessary to perform the two-step goodwill impairment test. If it is determined that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, the two-step test is performed to identify potential goodwill impairment. Based on certain circumstances, the Company may elect to bypass the qualitative assessment and proceed directly to performing the first step of the two-step goodwill impairment test, which compares the fair value of the Company’s reporting units to their related carrying values, including goodwill. If the fair value of the reporting unit is less than its carrying value, the Company performs an additional step to determine the implied fair value of goodwill associated with that reporting unit. The implied fair value of goodwill is determined by first allocating the fair value of the reporting unit to all of its assets and liabilities and then computing the excess of the reporting unit’s fair value over the amounts assigned to the assets and liabilities. If the carrying value of goodwill exceeds the implied fair value of goodwill, such excess represents the amount of goodwill impairment, and, accordingly, the Company recognizes such impairment. The Company’s goodwill impairment analysis also includes a comparison of the aggregate estimated fair value of its two reporting units to the Company’s total market capitalization.
   

12


6.
Other Intangible Assets

The following table summarizes the components of gross and net acquired intangible assets:
 
 
Gross
 
Accumulated
Amortization
 
Accumulated
Impairment
 
Net
Carrying
Value
 
 
 
 
 
 
(in millions)
 
 
December 30, 2017
 
 
 
 
 
 
 
 
Marketing-related intangible assets – amortizable
 
$
16.9

 
$
(13.1
)
 
$
—

 
$
3.8

Marketing-related intangible assets – nonamortizable
 
62.7

 
—

 
(26.0
)
 
36.7

Total
 
79.6

 
(13.1
)
 
(26.0
)
 
40.5

Customer-related intangible assets – amortizable
 
91.6

 
(33.9
)
 
—

 
57.7

Other acquired intangible assets – amortizable
 
22.1

 
(13.2
)
 
—

 
8.9

Other acquired intangible assets – nonamortizable
 
7.8

 
—

 
(1.2
)
 
6.6

Total
 
29.9

 
(13.2
)
 
(1.2
)
 
15.5

Total other intangible assets
 
$
201.1

 
$
(60.1
)
 
$
(27.2
)
 
$
113.7

 
 
Gross
 
Accumulated
Amortization
 
Accumulated
Impairment
 
Net
Carrying
Value
 
 
 
 
 
 
(in millions)
 
 
December 24, 2016
 
 
 
 
 
 
 
 
Marketing-related intangible assets – amortizable
 
$
14.9

 
$
(11.5
)
 
$
—

 
$
3.4

Marketing-related intangible assets – nonamortizable
 
62.8

 
—

 
(26.0
)
 
36.8

Total
 
77.7

 
(11.5
)
 
(26.0
)
 
40.2

Customer-related intangible assets – amortizable
 
64.3

 
(27.0
)
 
—

 
37.3

Other acquired intangible assets – amortizable
 
20.8

 
(11.9
)
 
—

 
8.9

Other acquired intangible assets – nonamortizable
 
7.7

 
—

 
(1.2
)
 
6.5

Total
 
28.5

 
(11.9
)
 
(1.2
)
 
15.4

Total other intangible assets
 
$
170.5

 
$
(50.4
)
 
$
(27.2
)
 
$
92.9

 
 
Gross
 
Accumulated
Amortization
 
Accumulated
Impairment
 
Net
Carrying
Value
 
 
 
 
 
 
(in millions)
 
 
September 30, 2017
 
 
 
 
 
 
 
 
Marketing-related intangible assets – amortizable
 
$
16.9

 
$
(12.7
)
 
$
—

 
$
4.2

Marketing-related intangible assets – nonamortizable
 
62.7

 
—

 
(26.0
)
 
36.7

Total
 
79.6

 
(12.7
)
 
(26.0
)
 
40.9

Customer-related intangible assets – amortizable
 
91.6

 
(32.2
)
 
—

 
59.4

Other acquired intangible assets – amortizable
 
22.1

 
(12.9
)
 
—

 
9.2

Other acquired intangible assets – nonamortizable
 
7.8

 
—

 
(1.2
)
 
6.6

Total
 
29.9

 
(12.9
)
 
(1.2
)
 
15.8

Total other intangible assets
 
$
201.1

 
$
(57.8
)
 
$
(27.2
)
 
$
116.1

Other acquired intangible assets include contract-based and technology-based intangible assets.
The Company evaluates long-lived assets, including amortizable and indefinite-lived intangible assets, for impairment whenever events or changes in circumstances indicate the carrying value may not be recoverable. The Company evaluates indefinite-lived intangible assets on an annual basis. Other factors indicating the carrying value of the Company’s amortizable intangible assets may not be recoverable were not present in fiscal 2017 or during the three months ended December 30, 2017, and accordingly, no impairment testing was performed on these assets.

13


The Company amortizes its acquired intangible assets with definite lives over periods ranging from 3 to 25 years; over weighted average remaining lives of 4 years for marketing-related intangibles, 10 years for customer-related intangibles and 11 years for other acquired intangibles. Amortization expense for intangibles subject to amortization was approximately $2.3 million and $1.4 million for the three months ended December 30, 2017 and December 24, 2016, respectively, and is classified within operating expenses in the condensed consolidated statements of operations. Estimated annual amortization expense related to acquired intangible assets in each of the succeeding five years is estimated to be approximately $8 million per year from fiscal 2018 through fiscal 2022
.
7.
Long-Term Debt
Long-term debt consists of the following:
 
 
December 30, 2017
 
December 24, 2016
 
September 30, 2017
 
 
(in thousands)
Senior notes, interest at 6.125%, payable semi-annually, principal due November 2023
 
$
400,000

 
$
400,000

 
$
400,000

Senior notes, interest at 5.125%, payable semi-annually, principal due February 2028
 
300,000

 
—

 
—

Unamortized debt issuance costs
 
(9,161
)
 
(5,436
)
 
(4,840
)
Net carrying value
 
690,839

 
394,564

 
395,160

Asset-based revolving credit facility, interest at LIBOR plus a margin of 1.25% to 1.50% or Base Rate plus a margin of 0.25% to 0.50%, final maturity April 2021
 
—

 
—

 
—

Other notes payable
 
497

 
844

 
493

Total
 
691,336

 
395,408

 
395,653

Less current portion
 
(372
)
 
(397
)
 
(375
)
Long-term portion
 
$
690,964

 
$
395,011

 
$
395,278

Senior Notes
$300 Million 5.125% Senior Notes
On December 14, 2017, the Company issued $300 million aggregate principal amount of 5.125% senior notes due February 2028 (the "2028 Notes"). The Company will use the net proceeds from the offering to finance future acquisitions and for general corporate purposes.
The Company incurred approximately $4.6 million of debt issuance costs in conjunction with this transaction, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2028 Notes.
The 2028 Notes require semiannual interest payments on February 1 and August 1, commencing August 1, 2018. The 2028 Notes are unconditionally guaranteed on a senior basis by the Company's existing and future domestic restricted subsidiaries who are borrowers under or guarantors of Central's senior secured revolving credit facility or who guarantee the 2023 Notes.
The Company may redeem some or all of the 2028 Notes at any time, at its option, prior to January 1, 2023 at the principal amount plus a “make whole” premium. At any time prior to January 1, 2021, the Company may also redeem, at its option, up to 35% of the original aggregate principal amount of the notes with the proceeds of certain equity offerings at a redemption price of 105.125% of the principal amount of the notes. The Company may redeem some or all of the 2028 Notes, at its option, at any time on or after January 1, 2023 for 102.563%, on or after January 1, 2024 for 101.708%, on or after January 1, 2025 for 100.854%, and on or after January 1, 2026 for 100.0%, plus accrued and unpaid interest.
The holders of the 2028 Notes have the right to require us to repurchase all or a portion of the 2028 Notes at a purchase price equal to 101% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.
The 2028 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. The Company was in compliance with all covenants as of December 30, 2017.

14


$400 Million 6.125% Senior Notes
On November 9, 2015, the Company issued $400 million aggregate principal amount of 6.125% senior notes due November 2023 (the "2023 Notes"). In December 2015, the Company used the net proceeds from the offering, together with available cash, to redeem its $400 million aggregate principal amount of 8.25% senior subordinated notes due March 1, 2018 ("2018 Notes") at a price of 102.063% of the principal amount and to pay fees and expenses related to the offering. The 2023 Notes are unsecured senior obligations and are subordinated to all of the Company’s existing and future secured debt, including the Company’s Credit Facility, to the extent of the value of the collateral securing such indebtedness.
The Company incurred approximately $6.3 million of debt issuance costs in conjunction with these transactions, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2023 Notes.
The 2023 Notes require semiannual interest payments on May 15 and November 15. The 2023 Notes are unconditionally guaranteed on a senior basis by each of the Company’s existing and future domestic restricted subsidiaries which are borrowers under or guarantors of Central’s senior secured revolving credit facility. The 2023 Notes are unsecured senior obligations and are subordinated to all of the Company’s existing and future secured debt, including the Company’s Credit Facility, to the extent of the value of the collateral securing such indebtedness.
The Company may redeem some or all of the 2023 Notes at any time, at its option, prior to November 15, 2018 at the principal amount plus a “make whole” premium. At any time prior to November 15, 2018, the Company may also redeem, at its option, up to 35% of the original aggregate principal amount of the notes with the proceeds of certain equity offerings at a redemption price of 106.125% of the principal amount of the notes. The Company may redeem some or all of the 2023 Notes, at its option, at any time on or after November 15, 2018 for 104.594%, on or after November 15, 2019 for 103.063%, on or after November 15, 2020 for 101.531% and on or after November 15, 2021 for 100%, plus accrued and unpaid interest.
The holders of the 2023 Notes have the right to require the Company to repurchase all or a portion of the 2023 Notes at a purchase price equal to 101% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.
The 2023 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. The Company was in compliance with all covenants as of December 30, 2017.
Asset-Based Loan Facility Amendment
On April 22, 2016, the Company entered into an amended and restated credit agreement which provides up to a $400 million principal amount senior secured asset-based revolving credit facility, with up to an additional $200 million principal amount available with the consent of the Lenders if the Company exercises the accordion feature set forth therein (collectively, the “Credit Facility”). The Credit Facility matures on April 22, 2021. The Company may borrow, repay and reborrow amounts under the Credit Facility until its maturity date, at which time all amounts outstanding under the Credit Facility must be repaid in full. As of December 30, 2017, there were no borrowings outstanding and no letters of credit outstanding under the Credit Facility. There were other letters of credit of $1.8 million outstanding as of December 30, 2017.
The Credit Facility is subject to a borrowing base, calculated using a formula based upon eligible receivables and inventory, minus certain reserves and subject to restrictions. As of December 30, 2017, the borrowing base and remaining borrowing availability was $330.2 million. Borrowings under the Credit Facility bear interest at an index based on LIBOR or, at the option of the Company, the Base Rate (defined as the highest of (a) the SunTrust prime rate, (b) the Federal Funds Rate plus 0.5% and (c) one-month LIBOR plus 1.00%), plus, in either case, an applicable margin based on the Company’s consolidated senior leverage ratio. Such applicable margin for LIBOR-based borrowings fluctuates between 1.25% - 1.50%, and was 1.25% as of December 30, 2017, and such applicable margin for Base Rate borrowings fluctuates between 0.25%-0.5%, and was 0.25% as of December 30, 2017. As of December 30, 2017, the applicable interest rate related to Base Rate borrowings was 4.8%, and the applicable interest rate related to LIBOR-based borrowings was 2.8%.
The Company incurred approximately $1.2 million of debt issuance costs in conjunction with this transaction, which included underwriter fees, legal and accounting expenses. The debt issuance costs are being amortized over the term of the Credit Facility.
The Credit Facility contains customary covenants, including financial covenants which require the Company to maintain a minimum fixed charge coverage ratio of 1.00:1.00 upon reaching certain borrowing levels. The Credit Facility is secured by substantially all assets of the Company. The Company was in compliance with all financial covenants under the Credit Facility during the quarter ended December 30, 2017.

15


8.
Supplemental Equity Information
The following table provides a summary of the changes in the carrying amounts of equity attributable to controlling interest and noncontrolling interest for the three months ended December 30, 2017 and December 24, 2016.
 
 
Controlling Interest
 
 
 
 
(in thousands)
 
Common
Stock
 
Class A
Common
Stock
 
Class
B
Stock
 
Additional
Paid In
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total
 
Noncontrolling
Interest
 
Total
Balance September 30, 2017
 
$
122

 
$
380

 
$
16

 
$
396,790

 
$
239,329

 
$
(951
)
 
$
635,686

 
$
1,456

 
$
637,142

Comprehensive income
 
 
 
 
 
 
 
 
 
26,247

 
44

 
26,291

 
203

 
26,494

Amortization of share-based awards
 
 
 
 
 
 
 
2,143

 
 
 
 
 
2,143

 
 
 
2,143

Restricted share activity, including net share settlement
 
 
 

 
 
 
(2,397
)
 
 
 
 
 
(2,397
)
 
 
 
(2,397
)
Issuance of common stock, including net share settlement of stock options
 


 


 
 
 
166

 
 
 
 
 
166

 
 
 
166

Distribution to Noncontrolling interest
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1,597
)
 
(1,597
)
Balance December 30, 2017
 
$
122

 
$
380

 
$
16

 
$
396,702

 
$
265,576

 
$
(907
)
 
$
661,889

 
$
62

 
$
661,951


 
 
Controlling Interest
 
 
 
 
(in thousands)
 
Common
Stock
 
Class A
Common
Stock
 
Class
B
Stock
 
Additional
Paid In
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total
 
Noncontrolling
Interest
 
Total
Balance September 24, 2016
 
$
120

 
$
374

 
$
16

 
$
393,297

 
$
160,501

 
$
(1,294
)
 
$
553,014

 
$
1,573

 
$
554,587

Comprehensive income
 
 
 
 
 
 
 
 
 
7,637

 
(508
)
 
7,129

 
152

 
7,281

Amortization of share-based awards
 
 
 
 
 
 
 
2,118

 
 
 
 
 
2,118

 
 
 
2,118

Restricted share activity, including net share settlement
 
 
 
(1
)
 
 
 
(3,312
)
 
 
 
 
 
(3,313
)
 
 
 
(3,313
)
Issuance of common stock, including net share settlement of stock options
 

 
2

 
 
 
(4,033
)
 
 
 
 
 
(4,031
)
 
 
 
(4,031
)
Tax benefit on stock option exercise, net of tax deficiency
 
 
 
 
 
 
 
4,332

 
 
 
 
 
4,332

 
 
 
4,332

Distribution to Noncontrolling interest
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1,018
)
 
(1,018
)
Balance December 24, 2016
 
$
120

 
$
375

 
$
16

 
$
392,402

 
$
168,138

 
$
(1,802
)
 
$
559,249

 
$
707

 
$
559,956

 
9.
Stock-Based Compensation
The Company recognized share-based compensation expense of $2.7 million and $2.7 million for the three months ended December 30, 2017 and December 24, 2016, respectively, as a component of selling, general and administrative expenses. The tax benefit associated with share-based compensation expense for the three months ended December 30, 2017 and December 24, 2016 was $0.7 million and $1.0 million, respectively.
 

16




10.
Earnings Per Share
The following is a reconciliation of the numerators and denominators of the basic and diluted per share computations for income from continuing operations.
 
 
Three Months Ended
 
 
December 30, 2017
 
 
Income
 
Shares
 
Per Share
Basic EPS:
 
 
 
 
 
 
     Net income available to common shareholders
 
$
26,247

 
50,730

 
$
0.52

Effect of dilutive securities:
 
 
 
 
 
 
     Options to purchase common stock
 

 
1,147

 
(0.01
)
     Restricted shares
 

 
818

 
(0.01
)
Diluted EPS:
 

 

 

     Net income available to common shareholders
 
$
26,247

 
52,695

 
$
0.50

 
 
 
 
 
 
 
 
 
Three Months Ended
 
 
December 24, 2016
 
 
Income

Shares

Per Share
Basic EPS:






     Net income available to common shareholders

$
7,637


49,665


$
0.15

Effect of dilutive securities:






     Options to purchase common stock



1,356


—

     Restricted shares



789


—

Diluted EPS:






     Net income available to common shareholders

$
7,637


51,810


$
0.15

 
 
 
 
 
 
 

Options to purchase 2.4 million shares of common stock at prices ranging from $6.43 to $33.15 per share were outstanding at December 30, 2017, and options to purchase 2.9 million shares of common stock at prices ranging from $6.43 to $15.56 per share were outstanding at December 24, 2016.

For the three months ended December 30, 2017 and December 24, 2016, all options outstanding were included in the computation of diluted earnings per share.


17


11.
Segment Information

Management has determined that the Company has two operating segments, which are also reportable segments based on the level at which the Chief Operating Decision Maker reviews the results of operations to make decisions regarding performance assessment and resource allocation. These operating segments are Pet segment and Garden segment and are presented in the table below (in thousands).
 
 
 
Three Months Ended
 
 
December 30,
2017
 
December 24,
2016
Net sales:
 
 
 
 
Pet segment
 
$
325,084

 
$
304,046

Garden segment
 
116,927

 
115,452

Total net sales
 
$
442,011

 
$
419,498

 
 
 
 
 
Pet segment
 
36,176

 
33,406

Garden segment
 
2,300

 
2,676

Corporate
 
(15,955
)
 
(16,144
)
Total operating income
 
22,521

 
19,938

Interest expense - net
 
(7,218
)
 
(6,835
)
Other expense
 
(3,089
)
 
(967
)
Income tax (benefit) expense
 
(14,236
)
 
4,347

Income including noncontrolling interest
 
26,450

 
7,789

Net income attributable to noncontrolling interest
 
203

 
152

Net income attributable to Central Garden & Pet Company
 
$
26,247

 
$
7,637

Depreciation and amortization:
 
 
 
 
Pet segment
 
$
7,145

 
5,830

Garden segment
 
1,569

 
1,507

Corporate
 
2,449

 
2,672

Total depreciation and amortization
 
$
11,163

 
$
10,009

 
 
 
December 30,
2017
 
December 24,
2016
 
September 30,
2017
Assets:
 
 
 
 
 
 
Pet segment
 
$
620,681

 
$
575,192

 
$
612,337

Garden segment
 
356,821

 
354,674

 
311,026

Corporate
 
639,850

 
286,888

 
383,543

Total assets
 
$
1,617,352

 
$
1,216,754

 
$
1,306,906

Goodwill (included in corporate assets above):
 
 
 
 
 
 
Pet segment
 
$
250,802

 
$
224,912

 
$
250,802

Garden segment
 
5,473

 
5,473

 
5,473

Total goodwill
 
$
256,275

 
$
230,385

 
$
256,275



18


12.
Consolidating Condensed Financial Information of Guarantor Subsidiaries

Certain 100% wholly-owned subsidiaries of the Company (as listed below, collectively the “Guarantor Subsidiaries”) have guaranteed fully and unconditionally, on a joint and several basis, the obligation to pay principal and interest on the Company’s 2023 Notes and 2028 Notes. Certain subsidiaries and operating divisions are not guarantors of the 2023 Notes and 2028 Notes. Those subsidiaries that are guarantors and co-obligors of the 2023 Notes and 2028 Notes are as follows:
Farnam Companies, Inc.
Four Paws Products Ltd.
Gulfstream Home & Garden, Inc.
Hydro-Organics Wholesale, Inc.
IMS Trading, LLC
IMS Southern, LLC
K&H Manufacturing, LLC
Kaytee Products, Inc.
Matson, LLC
New England Pottery, LLC
Pennington Seed, Inc. (including Gro Tec, Inc., NEXGEN Turf Research, LLC and All-Glass Aquarium Co., Inc.)
Pets International, Ltd.
Segrest, Inc. (including Blue Springs Hatchery, Inc., Segrest Farms, Inc., Florida Tropical Distributors International, Inc., Sun Pet, Ltd, Aquatica Tropicals, Inc., Quality Pets, LLC and Midwest Tropicals, LLC)
T.F.H. Publications, Inc.
Wellmark International (including B2E Corporation, B2E Microbials, LLC, B2E Manufacturing, LLC, Four Star Microbial Products, LLC and B2E Biotech LLC)
In lieu of providing separate audited financial statements for the Guarantor Subsidiaries, the Company has included the accompanying consolidating condensed financial statements based on the Company’s understanding of the Securities and Exchange Commission’s interpretation and application of Rule 3-10 of the Securities and Exchange Commission’s Regulation S-X.


 

19


 
 
CONSOLIDATING CONDENSED STATEMENT OF OPERATIONS
 
 
Three Months Ended December 30, 2017
 
 
(in thousands)
 
 
Parent
 
Non-
Guarantor
Subsidiaries
 
Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
 
$
159,061

 
$
13,743

 
$
286,424

 
$
(17,217
)
 
$
442,011

Cost of goods sold and occupancy
 
125,479

 
11,816

 
189,051

 
(16,172
)
 
310,174

Gross profit
 
33,582

 
1,927

 
97,373

 
(1,045
)
 
131,837

Selling, general and administrative expenses
 
36,639

 
3,905

 
69,817

 
(1,045
)
 
109,316

Operating income (loss)
 
(3,057
)
 
(1,978
)
 
27,556

 
—

 
22,521

Interest expense
 
(7,385
)
 
(16
)
 
(4
)
 
—

 
(7,405
)
Interest income
 
186

 
1

 
—

 
—

 
187

Other (expense) income
 
(2,918
)
 
54

 
(225
)
 
—

 
(3,089
)
Income (loss) before taxes and equity in earnings (losses) of affiliates
 
(13,174
)
 
(1,939
)
 
27,327

 
—

 
12,214

Income tax expense (benefit)
 
14,425

 
1,282

 
(29,943
)
 
—

 
(14,236
)
Equity in earnings (losses) of affiliates
 
53,846

 
—

 
(2,900
)
 
(50,946
)
 
—

Net income (loss) including noncontrolling interest
 
26,247

 
(3,221
)
 
54,370

 
(50,946
)
 
26,450

Net income attributable to noncontrolling interest
 
—

 
203

 
—

 
—

 
203

Net income (loss) attributable to Central Garden & Pet Company
 
$
26,247

 
$
(3,424
)
 
$
54,370

 
$
(50,946
)
 
$
26,247

 
 
CONSOLIDATING CONDENSED STATEMENT OF OPERATIONS
 
 
Three Months Ended December 24, 2016
 
 
(in thousands)
 
 
Parent
 
Non-
Guarantor
Subsidiaries
 
Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
 
$
155,518

 
$
14,024

 
$
266,438

 
$
(16,482
)
 
$
419,498

Cost of goods sold and occupancy
 
121,136

 
11,678

 
181,440

 
(15,434
)
 
298,820

Gross profit
 
34,382

 
2,346

 
84,998

 
(1,048
)
 
120,678

Selling, general and administrative expenses
 
35,965

 
3,664

 
62,159

 
(1,048
)
 
100,740

Operating income (loss)
 
(1,583
)
 
(1,318
)
 
22,839

 
—

 
19,938

Interest expense
 
(6,851
)
 
(17
)
 
(5
)
 
—

 
(6,873
)
Interest income
 
38

 
—

 
—

 
—

 
38

Other expense
 
(603
)
 
(193
)
 
(171
)
 
—

 
(967
)
Income (loss) before taxes and equity in earnings (losses) of affiliates
 
(8,999
)
 
(1,528
)
 
22,663

 
—

 
12,136

Income tax expense (benefit)
 
(3,192
)
 
(411
)
 
7,950

 
—

 
4,347

Equity in earnings (losses) of affiliates
 
13,444

 
—

 
(811
)
 
(12,633
)
 
—

Net income (loss) including noncontrolling interest
 
7,637

 
(1,117
)
 
13,902

 
(12,633
)
 
7,789

Net income attributable to noncontrolling interest
 
—

 
152

 
—

 
—

 
152

Net income (loss) attributable to Central Garden & Pet Company
 
$
7,637

 
$
(1,269
)
 
$
13,902

 
$
(12,633
)
 
$
7,637




20




 
 
CONSOLIDATING CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
 
 
Three Months Ended December 30, 2017
 
 
(in thousands)
 
 
Parent
 
Non-
Guarantor
Subsidiaries
 
Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net income (loss)
 
$
26,247

 
$
(3,221
)
 
$
54,370

 
$
(50,946
)
 
$
26,450

Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
Foreign currency translation
 
44

 
43

 
(16
)
 
(27
)
 
44

Total comprehensive income (loss)
 
26,291

 
(3,178
)
 
54,354

 
(50,973
)
 
26,494

Comprehensive income attributable to noncontrolling interests
 
—

 
203

 
—

 
—

 
203

Comprehensive income (loss) attributable to Central Garden & Pet Company
 
$
26,291

 
$
(3,381
)
 
$
54,354

 
$
(50,973
)
 
$
26,291

 
 
CONSOLIDATING CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
 
 
Three Months Ended December 24, 2016
 
 
(in thousands)
 
 
Parent
 
Non-
Guarantor
Subsidiaries
 
Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net income (loss)
 
$
7,637

 
$
(1,117
)
 
$
13,902

 
$
(12,633
)
 
$
7,789

Other comprehensive loss:
 
 
 
 
 
 
 
 
 
 
Foreign currency translation

(508
)

(355
)

(50
)

405


(508
)
Total comprehensive income (loss)
 
7,129

 
(1,472
)
 
13,852

 
(12,228
)
 
7,281

Comprehensive income attributable to noncontrolling interests
 
—

 
152

 
—

 
—

 
152

Comprehensive income (loss) attributable to Central Garden & Pet Company
 
$
7,129

 
$
(1,624
)
 
$
13,852

 
$
(12,228
)
 
$
7,129






21


 
 
CONSOLIDATING CONDENSED BALANCE SHEET
 
 
December 30, 2017
 
 
(in thousands)
 
 
Parent
 
Non-
Guarantor
Subsidiaries
 
Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
277,608

 
$
5,858

 
$
—

 
$
—

 
$
283,466

Restricted cash
 
12,419

 
—

 
—

 
—

 
12,419

Accounts receivable, net
 
89,039

 
5,617

 
140,419

 
—

 
235,075

Inventories
 
141,788

 
12,723

 
285,910

 
—

 
440,421

Prepaid expenses and other
 
6,645

 
1,059

 
14,815

 
—

 
22,519

Total current assets
 
527,499

 
25,257

 
441,144

 
—

 
993,900

Land, buildings, improvements and equipment, net
 
35,972

 
4,180

 
139,078

 
—

 
179,230

Goodwill
 
15,058

 
—

 
241,217

 
—

 
256,275

Other long-term assets
 
55,752

 
2,032

 
143,741

 
(13,578
)
 
187,947

Intercompany receivable
 
38,956

 
—

 
677,979

 
(716,935
)
 
—

Investment in subsidiaries
 
1,437,506

 
—

 
—

 
(1,437,506
)
 
—

Total
 
$
2,110,743

 
$
31,469

 
$
1,643,159

 
$
(2,168,019
)
 
$
1,617,352

LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
 
Accounts payable
 
$
40,775

 
$
9,241

 
$
74,567

 
$
—

 
$
124,583

Accrued expenses
 
45,973

 
2,313

 
51,718

 
—

 
100,004

Current portion of long-term debt
 
—

 
—

 
372

 
—

 
372

Total current liabilities
 
86,748

 
11,554

 
126,657

 
—

 
224,959

Long-term debt
 
690,839

 
—

 
125

 
—

 
690,964

Intercompany payable
 
663,241

 
53,694

 
—

 
(716,935
)
 
—

Losses in excess of investment in subsidiaries
 
—

 
—

 
29,069

 
(29,069
)
 
—

Other long-term obligations
 
8,026

 
—

 
45,030

 
(13,578
)
 
39,478

Total Central Garden & Pet shareholders’ equity (deficit)
 
661,889

 
(33,841
)
 
1,442,278

 
(1,408,437
)
 
661,889

Noncontrolling interest
 
—

 
62

 
—

 
—

 
62

Total equity (deficit)
 
661,889

 
(33,779
)
 
1,442,278

 
(1,408,437
)
 
661,951

Total
 
$
2,110,743

 
$
31,469

 
$
1,643,159

 
$
(2,168,019
)
 
$
1,617,352


22


 
 
CONSOLIDATING CONDENSED BALANCE SHEET
 
 
December 24, 2016
 
 
(in thousands)
 
 
Parent
 
Non-
Guarantor
Subsidiaries
 
Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
1,772

 
$
3,997

 
$
812

 
$
—

 
$
6,581

Restricted cash
 
10,981

 
—

 
—

 
—

 
10,981

Accounts receivable, net
 
72,850

 
6,919

 
112,455

 
—

 
192,224

Inventories
 
137,615

 
15,435

 
277,121

 
—

 
430,171

Prepaid expenses and other
 
7,972

 
897

 
13,530

 
—

 
22,399

Total current assets
 
231,190

 
27,248

 
403,918

 
—

 
662,356

Land, buildings, improvements and equipment, net
 
39,384